These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26524031)

  • 21. [Inhibitory effect of compound cantharides capsule on the proliferation of xenografts of human hepatocellular carcinoma HepG(2)215 in mice].
    Han JJ; Yu JM; Wu HY; Liu JB; Song B; Xue DW
    Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):821-5. PubMed ID: 23291129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of human diffuse large B-cell lymphoma growth by JC polyomavirus-like particles delivering a suicide gene.
    Chao CN; Huang YL; Lin MC; Fang CY; Shen CH; Chen PL; Wang M; Chang D; Tseng CE
    J Transl Med; 2015 Jan; 13():29. PubMed ID: 25623859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Potential mechanism and prognostic value of promoter methylation of PRDM1 gene in diffuse large B cell lymphoma].
    Zhang XY; Ma ZP; Cui WL; Chen R; Glinaer A; Miao N; Li XX
    Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):831-837. PubMed ID: 28056297
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of neferine on CCL5 and CCR5 expression in SCG of type 2 diabetic rats.
    Li G; Xu H; Zhu S; Xu W; Qin S; Liu S; Tu G; Peng H; Qiu S; Yu S; Zhu Q; Fan B; Zheng C; Li G; Liang S
    Brain Res Bull; 2013 Jan; 90():79-87. PubMed ID: 23063706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The biological and clinical impact of inhibition of NF-κB-initiated apoptosis in diffuse large B cell lymphoma (DLBCL).
    Bavi P; Uddin S; Bu R; Ahmed M; Abubaker J; Balde V; Qadri Z; Ajarim D; Al-Dayel F; Hussain AR; Al-Kuraya KS
    J Pathol; 2011 Jul; 224(3):355-66. PubMed ID: 21506127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The critical role of RasGRP4 in the growth of diffuse large B cell lymphoma.
    Zhu L; Xia C; Wu L; Zhang Y; Liu J; Chen Y; Liu J; Xiao Y; Nie K; Huang L; Qu N; Yu H
    Cell Commun Signal; 2019 Aug; 17(1):92. PubMed ID: 31409422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-derived CCL5 does not contribute to breast cancer progression.
    Jayasinghe MM; Golden JM; Nair P; O'Donnell CM; Werner MT; Kurt RA
    Breast Cancer Res Treat; 2008 Oct; 111(3):511-21. PubMed ID: 17978871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-9 promotes cell survival and drug resistance in diffuse large B-cell lymphoma.
    Lv X; Feng L; Ge X; Lu K; Wang X
    J Exp Clin Cancer Res; 2016 Jul; 35(1):106. PubMed ID: 27364124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The microenvironment of DLBCL is characterized by noncanonical macrophages recruited by tumor-derived CCL5.
    Manfroi B; De Grandis M; Moreaux J; Tabruyn S; Mayol JF; Quintero M; Righini C; Sturm N; Aurrand-Lions M; Huard B
    Blood Adv; 2021 Nov; 5(21):4338-4351. PubMed ID: 34516642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of down-regulation of CC chemokine ligand 5 (CCL5) on proliferation of human breast cancer cells in vitro].
    Kuang JX; Wang WX; Sun SR; Wang WR; Yao XL
    Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):174-7. PubMed ID: 21575514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Klotho, an anti-aging gene, acts as a tumor suppressor and inhibitor of IGF-1R signaling in diffuse large B cell lymphoma.
    Zhou X; Fang X; Jiang Y; Geng L; Li X; Li Y; Lu K; Li P; Lv X; Wang X
    J Hematol Oncol; 2017 Feb; 10(1):37. PubMed ID: 28153033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma.
    Zhang M; Xu-Monette ZY; Li L; Manyam GC; Visco C; Tzankov A; Wang J; Montes-Moreno S; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; Han van Krieken J; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Parsons BM; Winter JN; Piris MA; Medeiros LJ; Pham LV; Young KH
    Aging (Albany NY); 2016 Dec; 8(12):3321-3340. PubMed ID: 27941215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fbw7 regulates apoptosis in activated B-cell like diffuse large B-cell lymphoma by targeting Stat3 for ubiquitylation and degradation.
    Yao S; Xu F; Chen Y; Ge Y; Zhang F; Huang H; Li L; Lin D; Luo X; Xu J; Luo D; Zhu X; Liu Y
    J Exp Clin Cancer Res; 2017 Jan; 36(1):10. PubMed ID: 28069035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
    Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
    Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [B cells from streptozotocin-induced mouse diabetic model inhibit insulin secretion of MIN-6 cells and promote production of insulin autoantibody].
    Qin M; Xu Q; Wang P; Tang Q; Sun J; Wei W; Huang B
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Dec; 31(12):1593-6. PubMed ID: 26648288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor activity of fucoidan against diffuse large B cell lymphoma in vitro and in vivo.
    Yang G; Zhang Q; Kong Y; Xie B; Gao M; Tao Y; Xu H; Zhan F; Dai B; Shi J; Wu X
    Acta Biochim Biophys Sin (Shanghai); 2015 Nov; 47(11):925-31. PubMed ID: 26358321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of topical external administration of recombinant human epidermal growth factor on expression of epidermal growth factor receptor and its mRNA in scald wound of diabetes mellitus rat].
    Zong S; Liang Z; Ou B
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2010 Feb; 24(2):150-5. PubMed ID: 20187444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary central nervous system diffuse large B-cell lymphoma shows an activated B-cell-like phenotype with co-expression of C-MYC, BCL-2, and BCL-6.
    Li X; Huang Y; Bi C; Yuan J; He H; Zhang H; Yu Q; Fu K; Li D
    Pathol Res Pract; 2017 Jun; 213(6):659-665. PubMed ID: 28552541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic strategy with artificially-designed i-lncRNA targeting multiple oncogenic microRNAs exhibits effective antitumor activity in diffuse large B-cell lymphoma.
    Su Y; Sun B; Lin X; Zhao X; Ji W; He M; Qian H; Song X; Yang J; Wang J; Chen J
    Oncotarget; 2016 Aug; 7(31):49143-49155. PubMed ID: 27172795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A dual role for tumor-derived chemokine RANTES (CCL5).
    Adler EP; Lemken CA; Katchen NS; Kurt RA
    Immunol Lett; 2003 Dec; 90(2-3):187-94. PubMed ID: 14687724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.